Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celso Arango

Showing results (311-320 of 570) with videos related to

Pageof 57
Sort By:
The European Journal of Neuroscience|January 27, 2025
Prioritizing Brain Health in Youth: Bringing Neuroscience to Society and Informing Policy, Lessons Learnt from the European Brain Council Expert Meeting Held at the Federation of European Neuroscience Societies Forum 2024Suzanne L Dickson, Irene Tracey, Francesca Cirulli, et al.
Schizophrenia Research|February 3, 2007
The child and adolescent first-episode psychosis study (CAFEPS): design and baseline resultsJosefina Castro-Fornieles, Mara Parellada, Ana Gonzalez-Pinto, et al.
Medicina Clinica|April 15, 2008
[Factors related to the length of the corrected QT interval in patients treated with antipsychotics]David Fraguas Herráez, Paula Laita de Roda, Guillermo González Balmaseda, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Schizophrenia Bulletin|September 16, 2015
Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in PsychosisLaura Pina-Camacho, Ángel Del Rey-Mejías, Joost Janssen, et al.
Schizophrenia (Heidelberg, Germany)|March 1, 2026
Persistent negative symptoms in the EULAST cohort: impact on functional outcomeLuigi Giuliani, Pasquale Pezzella, Giulia M Giordano, et al.
Schizophrenia Bulletin|March 16, 2024
Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention StrategiesGonzalo Salazar de Pablo, Daniel Guinart, Alvaro Armendariz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 29, 2026
Precision medicine in mental health: applications, challenges, and recommendations - CORRIGENDUMCelso Arango, Eduard Vieta, Lourdes Fañañás, et al.
Journal of Clinical Medicine|September 10, 2021
Fronto-Parietal Gray Matter Volume Loss Is Associated with Decreased Working Memory Performance in Adolescents with a First Episode of PsychosisMarta Rapado-Castro, Mara Villar-Arenzana, Joost Janssen, et al.
Pageof 57

Showing results (311-320 of 570) with videos related to

Sort By:
Pageof 57
The European Journal of Neuroscience|January 27, 2025
Prioritizing Brain Health in Youth: Bringing Neuroscience to Society and Informing Policy, Lessons Learnt from the European Brain Council Expert Meeting Held at the Federation of European Neuroscience Societies Forum 2024Suzanne L Dickson, Irene Tracey, Francesca Cirulli, et al.
Schizophrenia Research|February 3, 2007
The child and adolescent first-episode psychosis study (CAFEPS): design and baseline resultsJosefina Castro-Fornieles, Mara Parellada, Ana Gonzalez-Pinto, et al.
Medicina Clinica|April 15, 2008
[Factors related to the length of the corrected QT interval in patients treated with antipsychotics]David Fraguas Herráez, Paula Laita de Roda, Guillermo González Balmaseda, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Schizophrenia Bulletin|September 16, 2015
Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in PsychosisLaura Pina-Camacho, Ángel Del Rey-Mejías, Joost Janssen, et al.
Schizophrenia (Heidelberg, Germany)|March 1, 2026
Persistent negative symptoms in the EULAST cohort: impact on functional outcomeLuigi Giuliani, Pasquale Pezzella, Giulia M Giordano, et al.
Schizophrenia Bulletin|March 16, 2024
Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention StrategiesGonzalo Salazar de Pablo, Daniel Guinart, Alvaro Armendariz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 29, 2026
Precision medicine in mental health: applications, challenges, and recommendations - CORRIGENDUMCelso Arango, Eduard Vieta, Lourdes Fañañás, et al.
Journal of Clinical Medicine|September 10, 2021
Fronto-Parietal Gray Matter Volume Loss Is Associated with Decreased Working Memory Performance in Adolescents with a First Episode of PsychosisMarta Rapado-Castro, Mara Villar-Arenzana, Joost Janssen, et al.
Pageof 57